860504 | C4 Ceramide (d18:1/4:0)
N-butyroyl-D-erythro-sphingosine

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
C4 Ceramide (d18:1/4:0)
N-butyroyl-D-erythro-sphingosine
CAS Registry Number is a Registered Trademark of the American Chemical Society
Caohuy H, Yang Q, Eudy Y, Ha TA, Xu AE, Glover M, Frizzell RA, Jozwik C, Pollard HB. Activation of 3-phosphoinositide-dependent kinase 1 (PDK1) and serum- and glucocorticoid-induced protein kinase 1 (SGK1) by short-chain sphingolipid C4-ceramide rescues the trafficking defect of ΔF508-cystic fibrosis transmembrane conductance regulator (ΔF508-CFTR). J Biol Chem. 2014 Dec 26;289(52):35953-68. doi: 10.1074/jbc.M114.598649. Epub 2014 Nov 10. PMID: 25384981; PMCID: PMC4276863.
PubMed ID: 25384981- Certificate of Analysis (Lot No. 860504P-5MG-A-010 and 5962PHA010)
- Certificate of Analysis (Lot No. 860504P-5MG-B-010 and 5962PHB010)
- Certificate of Analysis (Lot No. 860504P-5MG-C-010 and 5962PHC010)
- Certificate of Analysis (Lot No. 860504P-5MG-D-010 and 5962PHD010)
- Certificate of Analysis (Lot No. 860504P-5MG-G-010 and 5962PHG010)